Previous studies have inferred that type 2 diabetes diagnosed during adolescence is more fulminant compared to type 2 diabetes diagnosed during adulthood. One hypothesis to explain this disparity is the exaggerated loss of the insulin-producing β-cells in the pancreas. The only known significant source of unmethylated insulin DNA is through the death of β-cells; therefore, the ratio of serum unmethylated to methylated (U/M) insulin DNA, as measured by droplet digital PCR (ddPCR), is predicted to be proportional to the degree of β cell death. While this method has been explored to identify those at risk for type 1 diabetes, it has not been explored to characterize adolescents with type 2 diabetes. Some degree of β-cell loss may account for the exaggerated decompensation in glucose control over time seen in adolescents. The purpose of this pilot study was to determine the extent of β-cell death in adolescents with type 2 diabetes using this novel biomarker. We recruited 18 participants between the ages of 10 and 18 years with an established diagnosis of type 2 diabetes for a single fasting study visit. Genomic DNA was isolated from each participant and was templated for ddPCR using two different primer/probe sets (reported previously by Miramira and colleagues) that discriminated DNA from β-cell sources (unmethylated) and from non-β-cell peripheral tissues (methylated). The U/M ratio was inversely correlated with age (r=-0.72, p<0.001) and with age at diagnosis (r=-0.56, p=0.015) via Spearman correlation. These results suggest that younger adolescents with type 2 diabetes may exhibit more extensive β-cell death compared to older adolescents and that adolescents diagnosed at a younger age may exhibit more extensive β-cell death compared to those diagnosed at an older age as indicated by a higher ratio of U/M insulin DNA.

Disclosure

D.S. Hsia: None. S. Mercer: None. J. Collier: None. W.D. Johnson: None. K. Mccormick: None.

Funding

National Institute of General Medical Sciences (U54GM104940); National Center for Advancing Translational Sciences (UL1TR001417)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.